The presence of alloantibodies can complicate future blood transfusions, as finding compatible blood becomes challenging. In pregnancy, maternal alloantibodies can cross the placenta and attack fetal RBCs, leading to conditions like HDFN. This can cause fetal anemia, jaundice, or even fetal death if not managed properly.
